Skip to main content
Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · IEX Real-Time Price · USD
38.21
-0.37 (-0.96%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
 Current2023
Market Capitalization
2,2341,416
Enterprise Value
1,4191,022
PE Ratio
--16.86
PB Ratio
2.793.73
P/FCF Ratio
-34.93-18.90
P/OCF Ratio
-35.12-18.94
EV/EBITDA Ratio
-24.73-12.19
EV/EBIT Ratio
-24.64-12.17
EV/FCF Ratio
-26.48-13.65
Debt / Equity Ratio
0.000.01
Debt / EBITDA Ratio
-0.02-0.02
Debt / FCF Ratio
-0.02-0.03
Quick Ratio
37.8719.24
Current Ratio
38.0819.38
Return on Equity (ROE)
-27.10%-49.50%
Return on Assets (ROA)
-23.20%-30.50%
Return on Capital (ROIC)
-14.76%-24.35%
Earnings Yield
-4.64%-5.93%
FCF Yield
-4.31%-5.29%
Buyback Yield / Dilution
-903.80%-915.57%
Total Shareholder Return
-903.80%-915.57%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).